Overall, these data suggest that Treg, either at cellular levels through surface protein like CD40/CD40L interaction, or together with its promoting and signature cytokines, IL-10 and TGF-β, as well as downstream dioxygenase IDO, exert strong anti-inflammatory functions and suppress lesion development in atherosclerosis. The gene discussed is IDO1; the disease is atherosclerosis.